Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma

Clinical trial NCT03014804 · WITHDRAWN

Trial details

NCT number: NCT03014804
Sponsor: Jonsson Comprehensive Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Giant Cell Glioblastoma Gliosarcoma Oligodendroglioma Recurrent Glioblastoma Small Cell Glioblastoma

Start date: 2019-12-01
Primary completion: 2020-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.